Investing Profile

Michael Liang

InvestorVC
Venture Capital Investor in the Healthcare Sector at Baird Capital
Photo of Michael Liang, Venture Partner at Baird Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Baird Capital Venture Partner
$100K - $5.0M
$1.5M
19
$310M
CompanyStageDateRound SizeTotal Raised
Alto Neuroscience
Series CNov 2023$45M
$130M
Co-investors: Stephen Hays (What If Ventures), Christian Angermayer (Presight Capital), Martin Alexander Gershon (Endeavor Venture Funds), Tim Kendall
Greenlight Biosciences
Series DJun 2020$100M
Series UnknownMay 2020$17M
Series UnknownJan 2019$50M
$170M
OncoHealth
Series CMay 2020$28M
$51M
Co-investors: Annie Lamont (Oak HC/FT), Eugene Zhang (TSVC Capital), David Wu (Maveron)
Zurex Pharma
Series DJun 2018$9M
Series BJul 2014$4M
Series AMay 2012$6M
$19M
Amphora Medical
Series BJul 2017$36M
$36M
Co-investors: Ketan Patel (F-Prime Capital Partners)
Veniti
Series CMar 2015$17M
Series BJun 2013$10M
Series AMar 2011$14M
$41M
Integrated Diagnostics
Series BApr 2014$32M
$78M
Co-investors: Doug Fisher (InterWest)
Insightra Medical
Series COct 2013